Events & Media
This conference focus on the latest results from leading international research groups in the field of Ca-conducting cation channels. Some of these "calcium channels" are already known targets for approved drugs. Young scientists have the opportunity to present their results for discussion. This event are intended to draw the attention of the interested public to the research area and to stimulate scientific exchange in Germany, Austria and beyond.
The Life Science PhD Meeting provides a platform for scientists from the MUI and LFU, from undergraduate students up to PIs, to share their science, knowledge, experience and critical thinking. Furthermore, this is the ideal platform to encourage younger students to present their research for the first time to train this important skill for international conferences. The participants of the Life Science Meeting present excellent scientific work from numerous fields, which is only possible due to the huge variety of scientific interests from the many PhDresearch programs represented at the meeting.
ON THE MEDIA
2023
| A | B | C | D |
|---|
|
06/2024
|
Diabetes und Geschlecht
| Wissenswert | P. Tuluc |
|
09/2023
|
Wenn die Gehirnzellen nicht richtig kommunizieren
| You Tube FWF | J. Striessnig |
|
09/2023
|
Vorgestellt: Nadine Jasmin Ortner
| LFU, #gemeinsam | J. Striessnig |
|
07/2023
|
Atmen und Riechen gegen die Angst
| scilog | N. Singewald |
|
05/2023
|
ÖAZ- Alumni-Pharmazie-Treffen
| ÖAZ | N. Singewald, A. Weidmann |
|
03/2023
|
Lebenswichtige Kalziumkanäle gemeinsam erforschen
| Universität Innsbruck | P.Tuluc, / A. Koschak / N. Ortner (CaxX PhD programme) |
|
01/2023
| Internationale Experten eröffnen neuen Pharmazie-Master | Universität Innsbruck | J. Striessnig |
2022
| A | B | C | D |
|---|
|
08/2022
| Neue Studienangebote an der Universität Innsbruck - Masterstudium Pharmaceutical Sciences | APA | J. Striessnig |
|
06/2022
| Epigenetics: Is DNA methylation a way forward in the treatment of anxiety? | Progress in Mind | N. Singewald |
|
02/2022
|
Forschungsgruppen Netzwerk FG 18 genehmigt: „Neurobiologie der Angst bei Autismus-Spektrum-Störungen“
| Med Uni Innsbruck | N. Singewald |
2021
| A | B | C | D |
|---|
|
09/2021
|
Zwölf FWF-Projekte bewilligt
| Universität Innsbruck | J. Striessnig / N. Singewald |
|
09/2021
|
EVI TOP LIST of Women in European Vision Research and Ophthalmology 2021
| vision-research.eu | A. Koschak / Molecular sensory physiology group |
| 04/2021 |
Kalziumkanal: Krankheitsgen für neuronale Entwicklungsstörung
| Universität Innsbruck | CavX Phd Program / El Ghaleb et al. |
|
03/2021
|
Meditation als mögliche Therapie bei Angststörungen
| credoweb |
N. Singewald / Neuropharmacology Group
Gizewski et al. (Brain Behav.)
|
|
01/2021
|
Beste Dissertationen ausgezeichnet
| Universität Innsbruck | Nadja Hofer, Anita Siller, Nadine Ortner, Jörg Striessnig |
2020
| A | B | C | D |
|---|
|
01/2020
|
Universität Innsbruck: Vier der meistzitierten Forscher
| Universität Innsbruck | Jörg Striessnig |
|
10/2020
|
On the objectivity, reliability, and validity of deep learning enabled bioimage analyses
| eLife Sciences | N. Singewald / Neuropharmacology Group |
|
02/2020
|
Förderung des TWF vergeben
|
Universität Innsbruck
| N. Singewald, K. Ebner / Neuropharmacology Group |
| 02/2020 |
Erfolgreiche Nachwuchsforscher
|
Universität Innsbruck
| J. Striessnig |
2019
| A | B | C | D |
|---|
| 11/2019 | Wie Angst unser Gehirn verändert |
Medical University
| N. Singewald / Neuropharmacology Group / SFB-f44 Project |
| 07/2019 | Bipolare Zellen in der Netzhaut |
Universität Innsbruck
| A. Koschak / Molecular sensory physiology grou |
